Published in Behav Pharmacol on April 01, 2016
The ketamine-like compound methoxetamine substitutes for ketamine in the self-administration paradigm and enhances mesolimbic dopaminergic transmission. Psychopharmacology (Berl) (2016) 0.76
Methoxetamine affects brain processing involved in emotional response in rats. Br J Pharmacol (2017) 0.75
Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids. Prog Neuropsychopharmacol Biol Psychiatry (2012) 2.87
Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats. J Pharmacol Exp Ther (2008) 1.29
Cannabinoid self-administration increases dopamine release in the nucleus accumbens. Neuroreport (2006) 1.09
CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid-seeking behaviour in the rat. Br J Pharmacol (2004) 1.08
Peroxisome proliferator-activated receptors-alpha modulate dopamine cell activity through nicotinic receptors. Biol Psychiatry (2010) 1.05
Nicotinic alpha 7 receptors as a new target for treatment of cannabis abuse. J Neurosci (2007) 1.04
Strain and schedule-dependent differences in the acquisition, maintenance and extinction of intravenous cannabinoid self-administration in rats. Neuropharmacology (2006) 0.99
The GABAB receptor agonist baclofen prevents heroin-induced reinstatement of heroin-seeking behavior in rats. Neuropharmacology (2007) 0.97
PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors. J Neurosci (2013) 0.97
The suppression of appetite and food consumption by methylphenidate: the moderating effects of gender and weight status in healthy adults. Int J Neuropsychopharmacol (2011) 0.88
Cannabinoid self-administration attenuates PCP-induced schizophrenia-like symptoms in adult rats. Eur Neuropsychopharmacol (2010) 0.84
Cannabinoid CB1 and Dopamine D1 Receptors Partnership in the Modulation of Emotional Neural Processing. Front Behav Neurosci (2011) 0.81
Molecular mechanisms of cannabinoid addiction. Curr Opin Neurobiol (2013) 0.81
The role of the endocannabinoid system in eating disorders: neurochemical and behavioural preclinical evidence. Curr Pharm Des (2013) 0.78
Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats. Psychopharmacology (Berl) (2012) 0.77
Nicotine-seeking reinstatement is reduced by inhibition of instrumental memory reconsolidation. Behav Pharmacol (2014) 0.77
Behavioural and neurochemical assessment of salvinorin A abuse potential in the rat. Psychopharmacology (Berl) (2014) 0.77
Use of biocytin as neuroanatomic tracer in harvested human pancreas: a confocal laser scanning microscopy analysis. Pancreas (2002) 0.75
Methoxetamine, a novel psychoactive substance with serious adverse pharmacological effects: a review of case reports and preclinical findings. Behav Pharmacol (2016) 0.75